H.B. Fuller Reports First Quarter 2023 Results
H.B. Fuller Company (NYSE: FUL) reported first-quarter results, revealing a net income of $22 million and adjusted EBITDA of $110 million, at the high end of guidance. Total net revenue reached $809 million, down 5.5% year-on-year, attributed to a 2.5% drop in organic revenue due to lower volumes, despite favorable pricing that contributed 8.3 percentage points to organic growth.
The company initiated a restructuring plan aimed at cost savings of $30 to $35 million, while cash flow from operations improved by $23 million compared to last year. The forecast for full-year adjusted EBITDA remains $580 million to $610 million.
- Adjusted EBITDA increased by 6% year-on-year in constant currency.
- Calculated adjusted gross margin increased by 190 basis points year-on-year to 26.9%.
- Cash flow from operations improved by $23 million year-on-year.
- Net revenue decreased by 5.5% year-on-year to $809 million.
- Organic revenue declined by 2.5% year-on-year, primarily due to lower volume.
- Reported adjusted EPS of $0.55, down year-on-year, largely impacted by higher interest expense and unfavorable foreign currency effects.
Net income of
Adjusted EBITDA of
Pricing and raw material management results in year-on-year gross profit and EBITDA margin expansion
Lower working capital and improved margins drove higher cash flow from operations year-on-year
First Quarter 2023 Noteworthy Items:
-
Net revenue of
, down$809 million 5.5% year-on-year, in-line with Company expectations; organic revenue decreased2.5% year-on-year, driven by lower volume, offset by favorable pricing; -
Gross margin was
26.5% ; adjusted gross margin of26.9% increased 190 basis points year-on-year, driven by the combined effect of pricing and raw material cost developments; -
Net Income was
; adjusted EBITDA was$22 million , at the high end of Company expectations, and adjusted EBITDA margin expanded year-on-year to$110 million 13.6% ; -
Reported EPS (diluted) was
; adjusted EPS (diluted) was$0.39 , down versus the prior year, driven by lower volume, higher interest expense, and unfavorable foreign currency exchange; excluding the impacts of higher interest expense and unfavorable foreign currency, adjusted EPS (diluted) was up approximately$0.55 6% year-on-year; -
Cash flow from operations in the first quarter, historically our lowest cash flow quarter, improved
year-on-year;$23 million -
Initiated strategic restructuring to align cost structure to drive ongoing margin expansion and align with Construction Adhesives market demand, expected to generate annualized pre-tax run-rate cost savings of approximately
to$30 ;$35 million - Successfully completed a refinancing of a majority of outstanding debt, improving overall liquidity, extending maturities, and securing advantageous interest rate spreads.
Summary of First Quarter 2023 Results:
Net revenue for the first quarter of fiscal 2023 was
Consolidated organic growth was impacted by continued customer destocking and demand weakness affecting Construction Adhesives; however, the benefits of the Company’s geographic and end market diversification led to stable consolidated organic sales year-on-year. This was driven by Hygiene, Health and Consumable and Engineering Adhesives, which, on a combined basis, continued to generate positive organic growth in the first quarter.
Gross profit in the first quarter of fiscal 2023 was
Selling, general and administrative (SG&A) expense was
Net income attributable to
Adjusted EBITDA in the first quarter of fiscal 2023 was
“Despite challenging demand conditions, particularly in Construction Adhesives, our team executed exceptionally well to deliver solid first quarter results that were in-line with our expectations,” said
“Consistent with our strategic focus of continuously improving operational efficiency, we are implementing prudent and decisive actions to align our cost structure with lower volume expectations for 2023. These actions will lower our cost structure and improve the capacity utilization of our manufacturing network, allowing us to more effectively meet market needs and expand margins in-line with our long-term strategic plan.
“As we look ahead, we remain confident we will achieve our full-year guidance. We began to see margin expansion, driven by a combination of favorable price and raw material dynamics, and we expect this benefit to accelerate as we progress through the year and meaningfully benefit adjusted EBITDA margin. With our unique advantages and a more optimized cost structure, we are well positioned to continue creating value for shareholders and achieve our financial expectations for the year and beyond.”
Balance Sheet and Cash Flow Items:
During the first quarter, the Company successfully completed a refinancing of most of its debt. This extended maturities and improved liquidity, while maintaining favorable pricing. Net debt at the end of the first quarter of fiscal 2023 was
Cash flow from operations in the first quarter was
Restructuring:
During the first quarter, the Company initiated a restructuring plan to better align its cost structure with the current economic outlook, including high inflation and lower market demand. These actions are also consistent with the Company’s longer-term strategic objectives of improving gross profit and EBITDA margins and increasing return on invested capital (ROIC). The restructuring is focused on reducing both manufacturing costs and SG&A and is heavily weighted to Construction Adhesives.
As a result of these actions the Company expects to incur, on a pre-tax basis, one-time costs of approximately
Fiscal 2023 Outlook:
-
The Company continues to expect adjusted EBITDA for fiscal 2023 to be in the range of
to$580 million , equating to growth of approximately$610 million 9% to15% versus fiscal year 2022; -
Adjusted EPS (diluted) is now expected to be in the range of
to$4.10 , equating to growth of between$4.50 3% to13% year-on-year and fully diluted shares outstanding is now expected to be approximately 56 million; -
Revenue for fiscal 2023 is now expected to be down
1% to4% versus 2022; organic revenue for fiscal 2023 is now expected to be in the range of down1% to up1% , reflecting expected demand weakness in Construction Adhesives; -
Foreign currency translation is now expected to unfavorably impact net revenue growth by between
1% and2% in fiscal year 2023; -
Operating cash flow in fiscal 2023 is still expected to be between
and$300 million .$350 million
Conference Call:
The Company will hold a conference call on
Regulation G
The information presented in this earnings release regarding consolidated and segment organic revenue growth, operating income, adjusted gross profit, adjusted gross profit margin, adjusted selling, general and administrative expense, adjusted income before income taxes and income from equity investments, adjusted income taxes, adjusted effective tax rate, adjusted net income, adjusted diluted earnings per share and adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) does not conform to
About
Since 1887,
Safe Harbor for Forward-Looking Statements
Certain statements in this press release may be considered forward-looking statements within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements often address expected future business and financial performance, financial condition, and other matters, and often contain words or phrases such as “anticipate,” “believe,” “estimate,” “expect,” “intend,” “may,” “opportunity,” “outlook,” “plan,” “project,” “seek,” “should,” “strategy,” "target," “will,” “will be,” “will continue,” “will likely result,” “would” and similar expressions, and variations or negatives of these words or phrases. These statements are subject to various risks and uncertainties that could cause our actual results to differ materially from those in the forward-looking statements, including but not limited to the following: the consequences of the COVID-19 outbreak and other pandemics on our operations and financial results; the impact on the supply chain, raw material costs and pricing of our products due to the
Additional information about these various risks and uncertainties can be found in the “Risk Factors” section of our Form 10-K filings, and any updates to the risk factors in our Form 10-Q and 8-K filings with the
H.B. FULLER COMPANY AND SUBSIDIARIES |
CONSOLIDATED FINANCIAL INFORMATION |
In thousands, except per share amounts (unaudited) |
|
|
Three Months Ended
|
|
|
|
|
Three Months Ended
|
|
|
|
||||||
|
|
|
|
Percent of Net Revenue |
|
|
|
|
Percent of Net Revenue |
|
||||||
Net revenue |
|
$ |
809,183 |
|
|
|
100.0 |
% |
|
$ |
856,482 |
|
|
|
100.0 |
% |
Cost of sales |
|
|
(594,374 |
) |
|
|
(73.5 |
)% |
|
|
(643,589 |
) |
|
|
(75.1 |
)% |
Gross profit |
|
|
214,809 |
|
|
|
26.5 |
% |
|
|
212,893 |
|
|
|
24.9 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling, general and administrative expenses |
|
|
(154,542 |
) |
|
|
(19.1 |
)% |
|
|
(155,894 |
) |
|
|
(18.2 |
)% |
Other income, net |
|
|
2,604 |
|
|
|
0.3 |
% |
|
|
6,142 |
|
|
|
0.7 |
% |
Interest expense |
|
|
(33,069 |
) |
|
|
(4.1 |
)% |
|
|
(18,196 |
) |
|
|
(2.1 |
)% |
Interest income |
|
|
667 |
|
|
|
0.1 |
% |
|
|
1,940 |
|
|
|
0.2 |
% |
Income before income taxes and income from equity method investments |
|
|
30,469 |
|
|
|
3.8 |
% |
|
|
46,885 |
|
|
|
5.5 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income taxes |
|
|
(9,733 |
) |
|
|
(1.2 |
)% |
|
|
(10,148 |
) |
|
|
(1.2 |
)% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from equity method investments |
|
|
1,180 |
|
|
|
0.1 |
% |
|
|
1,583 |
|
|
|
0.2 |
% |
Net income including non-controlling interest |
|
|
21,916 |
|
|
|
2.7 |
% |
|
|
38,320 |
|
|
|
4.5 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income attributable to non-controlling interest |
|
|
(27 |
) |
|
|
(0.0 |
)% |
|
|
(14 |
) |
|
|
(0.0 |
)% |
Net income attributable to |
|
$ |
21,889 |
|
|
|
2.7 |
% |
|
$ |
38,306 |
|
|
|
4.5 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic income per common share attributable to |
|
$ |
0.40 |
|
|
|
|
|
|
$ |
0.72 |
|
|
|
|
|
Diluted income per common share attributable to |
|
$ |
0.39 |
|
|
|
|
|
|
$ |
0.69 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average common shares outstanding: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
|
54,174 |
|
|
|
|
|
|
|
53,353 |
|
|
|
|
|
Diluted |
|
|
55,919 |
|
|
|
|
|
|
|
55,395 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividends declared per common share |
|
$ |
0.190 |
|
|
|
|
|
|
$ |
0.168 |
|
|
|
|
|
H.B. FULLER COMPANY AND SUBSIDIARIES |
REGULATION G RECONCILIATION |
In thousands, except per share amounts (unaudited) |
|
|
Three Months Ended |
|
|||||
|
|
|
|
|
|
|
||
|
|
2023 |
|
|
2022 |
|
||
|
|
|
|
|
|
|
|
|
Net income attributable to |
|
$ |
21,889 |
|
|
$ |
38,306 |
|
|
|
|
|
|
|
|
|
|
Adjustments: |
|
|
|
|
|
|
|
|
Acquisition project costs1 |
|
|
2,235 |
|
|
|
5,857 |
|
Organizational realignment2 |
|
|
2,944 |
|
|
|
1,629 |
|
Royal restructuring and integration3 |
|
|
- |
|
|
|
398 |
|
Project One |
|
|
2,172 |
|
|
|
3,204 |
|
Other4 |
|
|
3,073 |
|
|
|
1,166 |
|
Discrete tax items5 |
|
|
846 |
|
|
|
(2,901 |
) |
Income tax effect on adjustments6 |
|
|
(2,400 |
) |
|
|
(3,510 |
) |
Adjusted net income attributable to |
|
|
30,759 |
|
|
|
44,149 |
|
|
|
|
|
|
|
|
|
|
Add: |
|
|
|
|
|
|
|
|
Interest expense |
|
|
30,380 |
|
|
|
18,210 |
|
Interest income |
|
|
(667 |
) |
|
|
(1,951 |
) |
Adjusted Income taxes |
|
|
11,286 |
|
|
|
16,559 |
|
Depreciation and Amortization expense8 |
|
|
37,914 |
|
|
|
35,797 |
|
Adjusted EBITDA7 |
|
$ |
109,672 |
|
|
$ |
112,764 |
|
|
|
|
|
|
|
|
|
|
Diluted Shares |
|
|
55,919 |
|
|
|
55,395 |
|
Adjusted diluted income per common share attributable to |
|
$ |
0.55 |
|
|
$ |
0.80 |
|
Revenue |
|
$ |
809,183 |
|
|
$ |
856,482 |
|
Adjusted EBITDA margin7 |
|
|
13.6 |
% |
|
|
13.2 |
% |
1 Acquisition project costs include costs related to integrating and accounting for acquisitions. |
2 Organizational realignment includes costs incurred as a direct result of the organizational realignment program, including compensation for employees supporting the program, consulting expense and operational inefficiencies related to the closure of production facilities and consolidation of business activities. |
3 Royal restructuring and integration program includes costs incurred as a direct result of the Royal restructuring and integration program including compensation for employees supporting the program, consulting expense and operational inefficiencies related to the closure of production facilities and consolidation of business activities. |
4 Other includes costs incurred for COVID-19 testing, vaccinations and exceptional medical claims, and non-cash gains and losses related to legal entity consolidations. |
5 Discrete tax items are related to various foreign tax matters, offset by excess tax benefit related to US stock compensation. |
6 Represents the difference between income taxes on net income before income taxes and income from equity method investments reported in accordance with |
7 Adjusted net income attributable to |
8 Depreciation and amortization expense added back for EBITDA is adjusted for amounts already included in adjusted net income attributable to |
H.B. FULLER COMPANY AND SUBSIDIARIES |
SEGMENT FINANCIAL INFORMATION |
In thousands (unaudited) |
|
|
Three Months Ended |
|
|||||
|
|
|
|
|
|
|
||
|
|
2023 |
|
|
2022 |
|
||
Net Revenue: |
|
|
|
|
|
|
|
|
Hygiene, Health and Consumable Adhesives |
|
$ |
383,528 |
|
|
$ |
389,538 |
|
Engineering Adhesives |
|
|
333,067 |
|
|
|
353,977 |
|
Construction Adhesives |
|
|
92,588 |
|
|
|
112,967 |
|
Corporate unallocated |
|
|
- |
|
|
|
- |
|
Total |
|
$ |
809,183 |
|
|
$ |
856,482 |
|
|
|
|
|
|
|
|
|
|
Segment Operating Income (Loss): |
|
|
|
|
|
|
|
|
Hygiene, Health and Consumable Adhesives |
|
$ |
45,146 |
|
|
$ |
32,213 |
|
Engineering Adhesives |
|
|
32,475 |
|
|
|
32,572 |
|
Construction Adhesives |
|
|
(9,634 |
) |
|
|
4,356 |
|
Corporate unallocated |
|
|
(7,720 |
) |
|
|
(12,142 |
) |
Total |
|
$ |
60,267 |
|
|
$ |
56,999 |
|
|
|
|
|
|
|
|
|
|
Adjusted EBITDA7 |
|
|
|
|
|
|
|
|
Hygiene, Health and Consumable Adhesives |
|
$ |
59,719 |
|
|
$ |
46,598 |
|
Engineering Adhesives |
|
|
49,876 |
|
|
|
49,879 |
|
Construction Adhesives |
|
|
2,845 |
|
|
|
15,877 |
|
Corporate unallocated |
|
|
(2,768 |
) |
|
|
410 |
|
Total |
|
$ |
109,672 |
|
|
$ |
112,764 |
|
|
|
|
|
|
|
|
|
|
Adjusted EBITDA Margin7 |
|
|
|
|
|
|
|
|
Hygiene, Health and Consumable Adhesives |
|
|
15.6 |
% |
|
|
12.0 |
% |
Engineering Adhesives |
|
|
15.0 |
% |
|
|
14.1 |
% |
Construction Adhesives |
|
|
3.1 |
% |
|
|
14.1 |
% |
Corporate unallocated |
|
NMP |
|
|
NMP |
|
||
Total |
|
|
13.6 |
% |
|
|
13.2 |
% |
|
|
|
|
|
|
|
|
|
NMP = non-meaningful percentage |
|
|
|
|
|
|
|
|
H.B. FULLER COMPANY AND SUBSIDIARIES |
REGULATION G RECONCILIATION |
In thousands, except per share amounts (unaudited) |
|
|
Three Months Ended |
|
|||||
|
|
|
|
|
|
|
||
|
|
2023 |
|
|
2022 |
|
||
Income before income taxes and income from equity method investments |
|
$ |
30,469 |
|
|
$ |
46,885 |
|
|
|
|
|
|
|
|
|
|
Adjustments: |
|
|
|
|
|
|
|
|
Acquisition project costs1 |
|
|
2,235 |
|
|
|
5,857 |
|
Organizational realignment2 |
|
|
2,944 |
|
|
|
1,629 |
|
Royal restructuring and integration3 |
|
|
- |
|
|
|
398 |
|
Project One |
|
|
2,172 |
|
|
|
3,204 |
|
Other4 |
|
|
3,073 |
|
|
|
1,166 |
|
Adjusted income before income taxes and income from equity method investments9 |
|
$ |
40,893 |
|
|
$ |
59,139 |
|
9 Adjusted income before income taxes and income from equity investments is a non-GAAP financial measure. Adjusted income before income taxes and income from equity investments is defined as income before income taxes and income from equity investments before the specific adjustments shown above. The table above provides a reconciliation of adjusted income before income taxes and income from equity investments to income before income taxes and income from equity investments, the most directly comparable financial measure determined and reported in accordance with |
H.B. FULLER COMPANY AND SUBSIDIARIES |
REGULATION G RECONCILIATION |
In thousands, except per share amounts (unaudited) |
|
|
Three Months Ended |
|
|||||
|
|
|
|
|
|
|
||
|
|
2023 |
|
|
2022 |
|
||
Income Taxes |
|
$ |
(9,733 |
) |
|
$ |
(10,148 |
) |
|
|
|
|
|
|
|
|
|
Adjustments: |
|
|
|
|
|
|
|
|
Acquisition project costs1 |
|
|
(514 |
) |
|
|
(1,678 |
) |
Organizational realignment2 |
|
|
(678 |
) |
|
|
(466 |
) |
Royal restructuring and integration3 |
|
|
- |
|
|
|
(114 |
) |
Project One |
|
|
(500 |
) |
|
|
(918 |
) |
Other4 |
|
|
139 |
|
|
|
(3,235 |
) |
Adjusted income taxes10 |
|
$ |
(11,286 |
) |
|
$ |
(16,559 |
) |
|
|
|
|
|
|
|
|
|
Adjusted income before income taxes and income from equity method investments |
|
$ |
40,893 |
|
|
$ |
59,139 |
|
Adjusted effective income tax rate10 |
|
|
27.6 |
% |
|
|
28.0 |
% |
10 Adjusted income taxes and adjusted effective income tax rate are non-GAAP financial measures. Adjusted income taxes is defined as income taxes before the specific adjustments shown above. Adjusted effective income tax rate is defined as income taxes divided by adjusted income before income taxes and income from equity method investments. The table above provides a reconciliation of adjusted income taxes and adjusted effective income tax rate to income taxes, the most directly comparable financial measure determined and reported in accordance with |
H.B. FULLER COMPANY AND SUBSIDIARIES |
REGULATION G RECONCILIATION |
In thousands (unaudited) |
|
|
Three Months Ended |
|
|||||
|
|
|
|
|
|
|
||
|
|
2023 |
|
|
2022 |
|
||
|
|
|
|
|
|
|
|
|
Net revenue |
|
$ |
809,183 |
|
|
$ |
856,482 |
|
|
|
|
|
|
|
|
|
|
Gross profit |
|
$ |
214,809 |
|
|
$ |
212,893 |
|
Gross profit margin |
|
|
26.5 |
% |
|
|
24.9 |
% |
|
|
|
|
|
|
|
|
|
Adjustments: |
|
|
|
|
|
|
|
|
Acquisition project costs1 |
|
|
43 |
|
|
|
662 |
|
Organizational realignment2 |
|
|
2,321 |
|
|
|
263 |
|
Royal restructuring and integration3 |
|
|
- |
|
|
|
233 |
|
Project One |
|
|
- |
|
|
|
- |
|
Other4 |
|
|
107 |
|
|
|
378 |
|
Adjusted gross profit11 |
|
$ |
217,280 |
|
|
$ |
214,429 |
|
Adjusted gross profit margin11 |
|
|
26.9 |
% |
|
|
25.0 |
% |
11 Adjusted gross profit and adjusted gross profit margin are non-GAAP financial measures. Adjusted gross profit and adjusted gross profit margin is defined as gross profit and gross profit margin excluding the specific adjustments shown above. The table above provides a reconciliation of adjusted gross profit and adjusted gross profit margin to gross profit and gross profit margin, the most directly comparable financial measure determined and reported in accordance with |
H.B. FULLER COMPANY AND SUBSIDIARIES |
REGULATION G RECONCILIATION |
In thousands (unaudited) |
|
|
Three Months Ended |
|
|||||
|
|
|
|
|
|
|
||
|
|
2023 |
|
|
2022 |
|
||
|
|
|
|
|
|
|
|
|
Selling, general and administrative expenses |
|
$ |
(154,542 |
) |
|
$ |
(155,894 |
) |
|
|
|
|
|
|
|
|
|
Adjustments: |
|
|
|
|
|
|
|
|
Acquisition project costs1 |
|
|
2,191 |
|
|
|
5,195 |
|
Organizational realignment2 |
|
|
622 |
|
|
|
1,354 |
|
Royal restructuring and integration3 |
|
|
- |
|
|
|
179 |
|
Project One |
|
|
2,172 |
|
|
|
3,204 |
|
Other4 |
|
|
263 |
|
|
|
675 |
|
Adjusted selling, general and administrative expenses12 |
|
$ |
(149,294 |
) |
|
$ |
(145,287 |
) |
12 Adjusted selling, general and administrative expenses is a non-GAAP financial measure. Adjusted selling, general and administrative expenses is defined as selling, general and administrative expenses excluding the specific adjustments shown above. The table above provides a reconciliation of adjusted selling, general and administrative expenses to selling, general and administrative expenses, the most directly comparable financial measure determined and reported in accordance with |
H.B. FULLER COMPANY AND SUBSIDIARIES |
REGULATION G RECONCILIATION |
In thousands (unaudited) |
|
|
Hygiene, Health |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended: |
|
and Consumable |
|
|
Engineering |
|
|
Construction |
|
|
|
|
|
|
Corporate |
|
|
|
|
|||||
|
|
Adhesives |
|
|
Adhesives |
|
|
Adhesives |
|
|
Total |
|
|
Unallocated |
|
|
Consolidated |
|
||||||
Net income attributable to |
|
$ |
47,707 |
|
|
$ |
34,350 |
|
|
$ |
(7,531 |
) |
|
$ |
74,526 |
|
|
$ |
(52,637 |
) |
|
$ |
21,889 |
|
Adjustments: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Acquisition project costs1 |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
2,235 |
|
|
|
2,235 |
|
Organizational realignment2 |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
2,944 |
|
|
|
2,944 |
|
Royal Restructuring and integration3 |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
Project One |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
2,172 |
|
|
|
2,172 |
|
Other4 |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
3,073 |
|
|
|
3,073 |
|
Discrete tax items5 |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
846 |
|
|
|
846 |
|
Income tax effect on adjustments6 |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(2,400 |
) |
|
|
(2,400 |
) |
Adjusted net income attributable to |
|
|
47,707 |
|
|
|
34,350 |
|
|
|
(7,531 |
) |
|
|
74,526 |
|
|
|
(43,767 |
) |
|
|
30,759 |
|
Add: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
30,380 |
|
|
|
30,380 |
|
Interest income |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(667 |
) |
|
|
(667 |
) |
Adjusted Income taxes |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
11,286 |
|
|
|
11,286 |
|
Depreciation and amortization expense8 |
|
|
12,012 |
|
|
|
15,526 |
|
|
|
10,376 |
|
|
|
37,914 |
|
|
|
- |
|
|
|
37,914 |
|
Adjusted EBITDA7 |
|
$ |
59,719 |
|
|
$ |
49,876 |
|
|
$ |
2,845 |
|
|
$ |
112,440 |
|
|
$ |
(2,768 |
) |
|
$ |
109,672 |
|
Revenue |
|
$ |
383,528 |
|
|
$ |
333,067 |
|
|
$ |
92,588 |
|
|
$ |
809,183 |
|
|
|
- |
|
|
$ |
809,183 |
|
Adjusted EBITDA Margin7 |
|
|
15.6 |
% |
|
|
15.0 |
% |
|
|
3.1 |
% |
|
|
13.9 |
% |
|
NMP |
|
|
|
13.6 |
% |
Note: Adjusted EBITDA is a non-GAAP financial measure. The table above provides a reconciliation of adjusted EBITDA for each segment to net income attributable to
|
NMP = Non-meaningful percentage |
H.B. FULLER COMPANY AND SUBSIDIARIES |
REGULATION G RECONCILIATION |
In thousands (unaudited) |
|
|
Hygiene, Health |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended: |
|
and Consumable |
|
|
Engineering |
|
|
Construction |
|
|
|
|
|
|
Corporate |
|
|
|
|
|||||
|
|
Adhesives |
|
|
Adhesives |
|
|
Adhesives |
|
|
Total |
|
|
Unallocated |
|
|
Consolidated |
|
||||||
Net income attributable to |
|
$ |
35,137 |
|
|
$ |
34,737 |
|
|
$ |
6,683 |
|
|
$ |
76,557 |
|
|
$ |
(38,251 |
) |
|
$ |
38,306 |
|
Adjustments: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Acquisition project costs1 |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
5,857 |
|
|
|
5,857 |
|
Organizational realignment2 |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
1,629 |
|
|
|
1,629 |
|
Royal Restructuring and integration3 |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
398 |
|
|
|
398 |
|
Project One |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
3,204 |
|
|
|
3,204 |
|
Other4 |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
1,166 |
|
|
|
1,166 |
|
Discrete tax items5 |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(2,901 |
) |
|
|
(2,901 |
) |
Income tax effect on adjustments6 |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(3,510 |
) |
|
|
(3,510 |
) |
Adjusted net income attributable to |
|
|
35,137 |
|
|
|
34,737 |
|
|
|
6,683 |
|
|
|
76,557 |
|
|
|
(32,408 |
) |
|
|
44,149 |
|
Add: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
18,210 |
|
|
|
18,210 |
|
Interest income |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(1,951 |
) |
|
|
(1,951 |
) |
Adjusted Income taxes |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
16,559 |
|
|
|
16,559 |
|
Depreciation and amortization expense8 |
|
|
11,461 |
|
|
|
15,142 |
|
|
|
9,194 |
|
|
|
35,797 |
|
|
|
- |
|
|
|
35,797 |
|
Adjusted EBITDA7 |
|
$ |
46,598 |
|
|
$ |
49,879 |
|
|
$ |
15,877 |
|
|
$ |
112,354 |
|
|
$ |
410 |
|
|
$ |
112,764 |
|
Revenue |
|
$ |
389,538 |
|
|
$ |
353,977 |
|
|
$ |
112,967 |
|
|
$ |
856,482 |
|
|
|
- |
|
|
$ |
856,482 |
|
Adjusted EBITDA Margin7 |
|
|
12.0 |
% |
|
|
14.1 |
% |
|
|
14.1 |
% |
|
|
13.1 |
% |
|
NMP |
|
|
|
13.2 |
% |
Note: Adjusted EBITDA is a non-GAAP financial measure. The table above provides a reconciliation of adjusted EBITDA for each segment to net income attributable to
|
NMP = Non-meaningful percentage |
H.B. FULLER COMPANY AND SUBSIDIARIES |
SEGMENT FINANCIAL INFORMATION |
NET REVENUE GROWTH (DECLINE) |
(unaudited) |
|
|
Three Months Ended |
||
|
|
|
||
Price |
|
|
8.3 |
% |
Volume |
|
|
(10.8 |
)% |
Organic Growth13 |
|
|
(2.5 |
)% |
M&A |
|
|
1.9 |
% |
Constant currency |
|
|
(0.6 |
)% |
F/X |
|
|
(4.9 |
)% |
Total H.B. Fuller Net Revenue Decline |
|
|
(5.5 |
)% |
Revenue growth versus 2022 |
|
Three Months Ended |
|
|||||||||||||||||
|
|
|
|
|||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net |
|
|
|
|
|
|
Constant |
|
|
|
|
|
|
Organic |
|
|||
|
|
Revenue |
|
|
F/X |
|
|
Currency |
|
|
M&A |
|
|
Growth13 |
|
|||||
Hygiene, Health and Consumable Adhesives |
|
|
(1.5 |
)% |
|
|
(6.2 |
)% |
|
|
4.7 |
% |
|
|
0.2 |
% |
|
|
4.5 |
% |
Engineering Adhesives |
|
|
(5.9 |
)% |
|
|
(4.5 |
)% |
|
|
(1.4 |
)% |
|
|
1.5 |
% |
|
|
(2.9 |
)% |
Construction Adhesives |
|
|
(18.0 |
)% |
|
|
(1.5 |
)% |
|
|
(16.5 |
)% |
|
|
9.3 |
% |
|
|
(25.8 |
)% |
Total |
|
|
(5.5 |
)% |
|
|
(4.9 |
)% |
|
|
(0.6 |
)% |
|
|
1.9 |
% |
|
|
(2.5 |
)% |
13 We use the term “organic revenue” to refer to net revenue, excluding the effect of foreign currency changes and acquisitions and divestitures. Organic growth reflects adjustments for the impact of period-over-period changes in foreign currency exchange rates on revenues and the revenues associated with acquisitions and divestitures. |
CONSOLIDATED BALANCE SHEETS |
|
(In thousands, except share and per share amounts) |
|
|
|
|
|
|
|
||
|
|
2023 |
|
|
2022 |
|
||
Assets |
|
|
|
|
|
|
|
|
Current assets: |
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
125,482 |
|
|
$ |
79,910 |
|
Trade receivables (net of allowances of |
|
|
566,358 |
|
|
|
607,365 |
|
Inventories |
|
|
526,041 |
|
|
|
491,781 |
|
Other current assets |
|
|
123,034 |
|
|
|
120,319 |
|
Total current assets |
|
|
1,340,915 |
|
|
|
1,299,375 |
|
|
|
|
|
|
|
|
|
|
Property, plant and equipment |
|
|
1,623,489 |
|
|
|
1,579,738 |
|
Accumulated depreciation |
|
|
(866,468 |
) |
|
|
(846,071 |
) |
Property, plant and equipment, net |
|
|
757,021 |
|
|
|
733,667 |
|
|
|
|
|
|
|
|
|
|
|
|
|
1,391,057 |
|
|
|
1,392,627 |
|
Other intangibles, net |
|
|
697,104 |
|
|
|
702,092 |
|
Other assets |
|
|
349,639 |
|
|
|
335,868 |
|
Total assets |
|
$ |
4,535,736 |
|
|
$ |
4,463,629 |
|
|
|
|
|
|
|
|
|
|
Liabilities, non-controlling interest and total equity |
|
|
|
|
|
|
|
|
Current liabilities |
|
|
|
|
|
|
|
|
Notes payable |
|
$ |
28,208 |
|
|
$ |
28,860 |
|
Trade payables |
|
|
450,203 |
|
|
|
460,669 |
|
Accrued compensation |
|
|
51,920 |
|
|
|
108,328 |
|
Income taxes payable |
|
|
16,348 |
|
|
|
18,530 |
|
Other accrued expenses |
|
|
96,497 |
|
|
|
89,345 |
|
Total current liabilities |
|
|
643,176 |
|
|
|
705,732 |
|
|
|
|
|
|
|
|
|
|
Long-term debt |
|
|
1,845,281 |
|
|
|
1,736,256 |
|
Accrued pension liabilities |
|
|
53,742 |
|
|
|
52,561 |
|
Other liabilities |
|
|
359,410 |
|
|
|
358,286 |
|
Total liabilities |
|
$ |
2,901,609 |
|
|
$ |
2,852,835 |
|
|
|
|
|
|
|
|
|
|
Commitments and contingencies (Note 12) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred stock (no shares outstanding) shares authorized – 10,045,900 |
|
|
- |
|
|
|
- |
|
Common stock, par value |
|
$ |
53,819 |
|
|
$ |
53,677 |
|
Additional paid-in capital |
|
|
272,820 |
|
|
|
266,491 |
|
Retained earnings |
|
|
1,752,943 |
|
|
|
1,741,359 |
|
Accumulated other comprehensive loss |
|
|
(446,116 |
) |
|
|
(451,357 |
) |
Total |
|
|
1,633,466 |
|
|
|
1,610,170 |
|
Non-controlling interest |
|
|
661 |
|
|
|
624 |
|
Total equity |
|
|
1,634,127 |
|
|
|
1,610,794 |
|
Total liabilities, non-controlling interest and total equity |
|
$ |
4,535,736 |
|
|
$ |
4,463,629 |
|
CONSOLIDATED STATEMENTS of CASH FLOWS |
|
(In thousands) |
|
|
Three Months Ended |
|
|||||
|
|
|
|
|
|
|
||
Cash flows from operating activities: |
|
|
|
|
|
|
|
|
Net income including non-controlling interest |
|
$ |
21,916 |
|
|
$ |
38,320 |
|
Adjustments to reconcile net income including non-controlling interest to net cash (used in) provided by operating activities: |
|
|
|
|
|
|
|
|
Depreciation |
|
|
19,248 |
|
|
|
18,163 |
|
Amortization |
|
|
18,683 |
|
|
|
17,792 |
|
Deferred income taxes |
|
|
(5,746 |
) |
|
|
(6,020 |
) |
Income from equity method investments, net of dividends received |
|
|
(1,180 |
) |
|
|
(1,583 |
) |
Debt issuance costs write-off |
|
|
2,689 |
|
|
|
- |
|
Loss on mark to market adjustment on contingent consideration liability |
|
|
139 |
|
|
|
- |
|
Gain on sale or disposal of assets |
|
|
(4 |
) |
|
|
(13 |
) |
Share-based compensation |
|
|
4,527 |
|
|
|
5,091 |
|
Pension and other post-retirement benefit plan activity |
|
|
(3,476 |
) |
|
|
(5,361 |
) |
Change in assets and liabilities, net of effects of acquisitions: |
|
|
|
|
|
|
|
|
Trade receivables, net |
|
|
55,407 |
|
|
|
13,283 |
|
Inventories |
|
|
(33,800 |
) |
|
|
(87,419 |
) |
Other assets |
|
|
(28,947 |
) |
|
|
(3,195 |
) |
Trade payables |
|
|
8,996 |
|
|
|
46,464 |
|
Accrued compensation |
|
|
(57,000 |
) |
|
|
(44,066 |
) |
Other accrued expenses |
|
|
(6,414 |
) |
|
|
(6,839 |
) |
Income taxes payable |
|
|
(2,235 |
) |
|
|
6,698 |
|
Other liabilities |
|
|
(3,085 |
) |
|
|
(8,810 |
) |
Other |
|
|
15,827 |
|
|
|
(178 |
) |
Net cash provided by (used in) operating activities |
|
|
5,545 |
|
|
|
(17,673 |
) |
|
|
|
|
|
|
|
|
|
Cash flows from investing activities: |
|
|
|
|
|
|
|
|
Purchased property, plant and equipment |
|
|
(47,604 |
) |
|
|
(48,883 |
) |
Purchased businesses, net of cash acquired |
|
|
(16,723 |
) |
|
|
(229,314 |
) |
Proceeds from sale of property, plant and equipment |
|
|
611 |
|
|
|
22 |
|
Cash received from government grant |
|
|
- |
|
|
|
3,928 |
|
Net cash used in investing activities |
|
|
(63,716 |
) |
|
|
(274,247 |
) |
|
|
|
|
|
|
|
|
|
Cash flows from financing activities: |
|
|
|
|
|
|
|
|
Proceeds from issuance of long-term debt |
|
|
1,300,000 |
|
|
|
307,500 |
|
Repayment of long-term debt |
|
|
(1,176,650 |
) |
|
|
- |
|
Payment of debt issuance costs |
|
|
(10,214 |
) |
|
|
(400 |
) |
Net payment of notes payable |
|
|
(881 |
) |
|
|
(7,604 |
) |
Dividends paid |
|
|
(10,222 |
) |
|
|
(8,881 |
) |
Contingent consideration payment |
|
|
- |
|
|
|
(5,000 |
) |
Proceeds from stock options exercised |
|
|
3,595 |
|
|
|
5,754 |
|
Repurchases of common stock |
|
|
(2,448 |
) |
|
|
(3,577 |
) |
Net cash provided by financing activities |
|
|
103,180 |
|
|
|
287,792 |
|
|
|
|
|
|
|
|
|
|
Effect of exchange rate changes on cash and cash equivalents |
|
|
563 |
|
|
|
5,853 |
|
Net change in cash and cash equivalents |
|
|
45,572 |
|
|
|
1,725 |
|
Cash and cash equivalents at beginning of period |
|
|
79,910 |
|
|
|
61,786 |
|
Cash and cash equivalents at end of period |
|
$ |
125,482 |
|
|
$ |
63,511 |
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20230329005704/en/
Investor Relations Contact
651-236-5060
Source:
FAQ
What were H.B. Fuller's earnings for the first quarter of 2023?
How did H.B. Fuller's revenue change in the first quarter of 2023?
What is the adjusted EPS for H.B. Fuller for Q1 2023?
What cost savings is H.B. Fuller expecting from its restructuring plan?